Richard Newitter
Stock Analyst at Truist Securities
(3.95)
# 564
Out of 5,127 analysts
444
Total ratings
49.44%
Success rate
11.07%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $120 → $95 | $74.12 | +28.17% | 21 | Feb 5, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $37 → $25 | $13.87 | +80.25% | 6 | Feb 2, 2026 | |
| PEN Penumbra | Downgrades: Hold | $370 → $374 | $339.05 | +10.31% | 8 | Jan 16, 2026 | |
| INSP Inspire Medical Systems | Maintains: Buy | $165 → $120 | $66.33 | +80.91% | 30 | Jan 8, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $230 → $215 | $148.50 | +44.78% | 19 | Dec 18, 2025 | |
| VCEL Vericel | Maintains: Buy | $50 → $45 | $35.44 | +26.98% | 6 | Dec 18, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $4 → $3 | $2.21 | +35.75% | 19 | Dec 18, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Hold | $17 → $24 | $18.89 | +27.05% | 4 | Dec 18, 2025 | |
| SYK Stryker | Maintains: Hold | $400 → $392 | $356.08 | +10.09% | 25 | Dec 18, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $50 → $47 | $29.21 | +60.90% | 16 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $110 → $107 | $101.65 | +5.26% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $82 | $65.21 | +25.75% | 22 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $650 | $492.84 | +31.89% | 32 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $86 → $95 | $85.46 | +11.16% | 12 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $412 → $390 | $245.57 | +58.81% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $113.27 | +28.01% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $92 | $76.80 | +19.79% | 22 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $87.59 | +19.88% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $11.96 | +67.22% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $94 → $82 | $70.16 | +16.88% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $10.93 | +37.24% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $106.21 | +28.99% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $16.71 | +43.63% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $89.73 | +25.93% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $15.38 | +36.54% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $8.26 | +142.13% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $78.44 | +4.54% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $207.39 | +20.55% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $3.83 | +578.85% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $192.50 | +300.00% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $75.02 | +13.30% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.37 | +61.68% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $33.93 | -20.42% | 5 | Feb 23, 2021 |
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $120 → $95
Current: $74.12
Upside: +28.17%
Beta Bionics
Feb 2, 2026
Maintains: Buy
Price Target: $37 → $25
Current: $13.87
Upside: +80.25%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $339.05
Upside: +10.31%
Inspire Medical Systems
Jan 8, 2026
Maintains: Buy
Price Target: $165 → $120
Current: $66.33
Upside: +80.91%
iRhythm Holdings
Dec 18, 2025
Maintains: Buy
Price Target: $230 → $215
Current: $148.50
Upside: +44.78%
Vericel
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $35.44
Upside: +26.98%
Treace Medical Concepts
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $2.21
Upside: +35.75%
Tandem Diabetes Care
Dec 18, 2025
Maintains: Hold
Price Target: $17 → $24
Current: $18.89
Upside: +27.05%
Stryker
Dec 18, 2025
Maintains: Hold
Price Target: $400 → $392
Current: $356.08
Upside: +10.09%
PROCEPT BioRobotics
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $47
Current: $29.21
Upside: +60.90%
Dec 18, 2025
Maintains: Hold
Price Target: $110 → $107
Current: $101.65
Upside: +5.26%
Dec 18, 2025
Maintains: Buy
Price Target: $80 → $82
Current: $65.21
Upside: +25.75%
Dec 18, 2025
Maintains: Buy
Price Target: $620 → $650
Current: $492.84
Upside: +31.89%
Dec 18, 2025
Maintains: Buy
Price Target: $86 → $95
Current: $85.46
Upside: +11.16%
Dec 18, 2025
Maintains: Buy
Price Target: $412 → $390
Current: $245.57
Upside: +58.81%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $113.27
Upside: +28.01%
Dec 5, 2025
Maintains: Hold
Price Target: $90 → $92
Current: $76.80
Upside: +19.79%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $87.59
Upside: +19.88%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $11.96
Upside: +67.22%
Nov 3, 2025
Reiterates: Buy
Price Target: $94 → $82
Current: $70.16
Upside: +16.88%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $10.93
Upside: +37.24%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $106.21
Upside: +28.99%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $16.71
Upside: +43.63%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $89.73
Upside: +25.93%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $15.38
Upside: +36.54%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $8.26
Upside: +142.13%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $78.44
Upside: +4.54%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $207.39
Upside: +20.55%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $3.83
Upside: +578.85%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $192.50
Upside: +300.00%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $75.02
Upside: +13.30%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.37
Upside: +61.68%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $33.93
Upside: -20.42%